1 completed, 1 recruiting, 1 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Ulcerative Colitis Chronic: new trials by email Literature Review of Ulcerative Colitis Chronic trials Research Report on Ulcerative Colitis Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis Mirikizumab - Ulcerative Colitis, Ulcerative Colitis Chronic | Phase 3 | Completed | Eli Lilly and Company | 172 | 2023-05-17 | 2026-06-10 |
| Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis Budesonide MMX, Prednisolone - Ulcerative Colitis Chronic | Phase 2 / Phase 3 | Unknown | Assiut University | 100 | 2022-06-01 | 2022-04-22 |
| A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) Mirikizumab - Ulcerative Colitis, Ulcerative Colitis Chronic | Phase 3 | Recruiting | Eli Lilly and Company | 150 | 2021-05-26 | 2026-10-07 |
Colitis, Ulcerative (3) · Crohn Disease (1) · Inflammatory Bowel Diseases (1) · Pediatric Crohn's disease (1) · Pediatric ulcerative colitis (1)
Colitis (3) · Colonic Diseases (3) · Digestive System Diseases (3) · Gastroenteritis (3) · Gastrointestinal Diseases (3) · Intestinal Diseases (3) · Inflammatory Bowel Diseases (2)
mirikizumab (2) · Prednisolone (1)
Eli Lilly and Company (2) · Assiut University (1)
Belgium (2) · Germany (2) · Italy (2) · Poland (2) · United Kingdom (2) · United States (2) · Austria (1) · Brazil (1) · Canada (1) · Czechia (1) · France (1) · Hungary (1) · Israel (1) · Japan (1) · Netherlands (1)